Tag: Merck

The Merck Group, branded and commonly known as Merck, is a German multinational chemical, pharmaceutical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

Merck to Develop Small-Molecule Inhibitors Against Several Cancer Drug Targets

Merck & Co. entered an agreement with two subsidiaries of Otsuka to develop small-molecule inhibitors against several cancer drug targets, including the KRAS oncogene. Under the deal, Merck wil...

FDA Approved Merck Ervebo

The U.S. Food and Drug Administration announced the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 yea...

FDA Recommended KEYTRUDA for Treatment of Certain Patients with NMIBC

fda
Merck, known as MSD outside the United States and Canada, announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) voted 9-4 in favor of recommending...

Merck Animal Health Announced Completion of Acquisition of Vaki

Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, announced the completion of its acquisition of Vaki, a leader in fish farming and wild fish conservation monitoring equ...

Nanolek and Merck Launched Full Production Cycle for CVD Treatment

nanolek
The biopharmaceutical company Nanolek together with Merck launches the production of a medicinal product for the treatment of cardiovascular diseases (CVD) in the Kirov region. The official start o...

Bioncotech Entered Clinical Trial Collaboration with Merck

merck-kgaa
Bioncotech Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces it has entered into a Phase II clinical trial collaboration with a subsidia...

Merck Agreed to Acquire ArQule for $2.7bn

Merck has signed an agreement to acquire biopharmaceutical company ArQule for a total equity value of around $2.7bn. ArQule is involved in the research and development of targeted therapeutics ...

Seattle Genetic and Astellas Pharma Announced Clinical Collaboration Agreement with Merck

Merck
Seattle Genetics, Inc. and Astellas Pharma Inc., announced a clinical collaboration agreement with Merck, known as MSD outside the United States and Canada through a subsidiary, to evaluate the combin...

‘Super Responders’ to Keytruda Shown in Prostate Cancer Study

clinical-trials
Results from a mid-stage trial published in the Journal of Clinical Oncology suggest that some men with advanced prostate cancer can live longer after receiving treatment with Merck & Co.'s Keytru...

Merck Therapy Keytruda Approved by NMPA for NSCLC Treatment

merck
Merck, known as MSD outside the United States and Canada, announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products Administration (NMPA) in China in combi...

BAVENCIO® Approved in Russia for Metastatic Merkel Carcinoma Treatment

merck kgaa
The Merck and Pfizer Alliance announced that the Ministry of Health of the Russian Federation has approved BAVENCIO® (avelumab, avelumab), as monotherapy in previously treated patients with metastatic...

Phase III Clinical Trials Confirmed Efficacy and Safety of Vericiguat

Merck, known as MSD outside the United States and Canada, announced that the Phase 3 VICTORIA study evaluating the efficacy and safety of vericiguat, a soluble guanylate cyclase (sGC) stimulator being...

EC Approved KEYTRUDA as HNSCC Treatment

Merck, known as MSD outside the United States and Canada, announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy or in combination with platinum and 5-...

Merck Get FDA Nod for Topical Solution for Cats BRAVECTO® PLUS

Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK), announced the U.S. approval of BRAVECTO® PLUS topical solution for cats by the U.S. Food and Drug Administr...

Accelerating Sales of Mavenclad Helped Mrck to Double-Digit Rise in Healthcare Sales

Accelerating sales of Merck KGaA’s oral multiple sclerosis therapy Mavenclad helped the company to a double-digit rise in healthcare sales in the third quarter, and a rise in its full-year revenue for...

Merck Agreed to Provide Evotec Access to CRISPR Gene-Editing Technology

gene therapy
Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck’s foundational CRISPR intellectual property. Evotec, an inte...